During the 8-week steroid-reduction phase, adult and pediatric patients will reduce 25% of the budesonide baseline dose every 2 weeks, depending of the asthma control, until reaching a 100% reduction of the baseline dose. The clinical control of asthma is defined according to criteria (GINA 2012)